| |
ATC |
1 Agents affecting nervous system and sensory organs
|
|
|
2 Agents affecting individual organs
|
|
|
3 Agents affecting metabolism
|
31 Vitamins
|
32 Nutrients, tonics
|
33 Blood and body fluid agents
|
34 Dialysis agents
|
39 Other agents affecting metabolism
|
391 Liver disease agents
|
392 Antidotes
|
393 Habitual intoxication agents
|
394 Gout preparations
|
395 Enzyme preparations
|
396 Antidiabetic agents
|
397 Metabolic disease preparations & combinations
|
399 Miscellaneous
|
3991 Chondroitins
|
3992 Adenosines
|
3993 Prolactins
|
3999 Others
|
D02397 Arginine glutamate (USAN)
D00352 Lactulose (JP16/USP/INN)
D02039 Lactitol hydrate (JAN)
D02030 Levocarnitine chloride (JAN)
D02176 Levocarnitine (JAN/USP/INN)
D00086 Thioctic acid (JAN)
D05032 Miglustat (JAN/USAN/INN)
D01798 Sapropterin hydrochloride (JAN); Sapropterin dihydrochloride (USAN)
D01766 Camostat mesilate (JP16)
D08990 Romiplostim (genetical recombination) (JAN); Romiplostim (USAN/INN)
D03978 Eltrombopag olamine (JAN/USAN)
D03231 Epoetin alfa (genetical recombination) (JP16); Epoetin alfa (USAN/INN)
D03232 Epoetin beta (genetical recombination) (JP16); Epoetin beta (USAN/INN)
D09737 Epoetin kappa (genetical recombination) (Epoetin alfa biosimilar 1) (JAN); Epoetin kappa (INN)
D09998 Epoetin beta pegol (genetical recombination) (JAN)
D03651 Darbepoetin alfa (genetical recombination) (JAN); Darbepoetin alfa (USAN/INN)
D01126 L-Arginine hydrochloride (JP16); Arginine hydrochloride (USP)
D00294 Diazoxide (JAN/USP/INN)
D03354 Purified sodium hyaluronate (JP16); Sodium hyaluronate (JAN); Hyaluronate sodium (USAN)
D01995 Inosine pranobex (JAN)
D00107 Tacrolimus hydrate (JP16); Tacrolimus (USAN/INN)
D02217 Raloxifene hydrochloride (JAN/USP)
D03062 Bazedoxifene acetate (JAN/USAN)
D00249 Calcitonin (salmon) (JP16); Calcitonin salmon (USAN/INN)
D03287 Elcatonin (JP16/INN)
D03505 Cinacalcet hydrochloride (JAN/USAN)
D00142 Methotrexate (JP16/USP/INN)
D02714 Everolimus (JAN/USAN/INN)
D00752 Mycophenolate mofetil (JAN/USAN)
D00749 Leflunomide (JAN/USAN/INN)
D01566 Gusperimus hydrochloride (JAN); Gusperimus trihydrochloride (USAN)
D03203 Abatacept (genetical recombination) (JAN); Abatacept (USAN/INN)
D04187 Fingolimod hydrochloride (JAN/USAN)
D00742 Etanercept (genetical recombination) (JAN); Etanercept (USAN/INN)
D02597 Adalimumab (genetical recombination) (JAN); Adalimumab (USAN/INN)
D03441 Certolizumab pegol (genetical recombination) (JAN); Certolizumab pegol (USAN/INN)
D04358 Golimumab (genetical recombination) (JAN); Golimumab (USAN/INN)
D09214 Ustekinumab (genetical recombination) (JAN); Ustekinumab (USAN/INN)
D09315 Canakinumab (genetical recombination) (JAN); Canakinumab (USAN/INN)
D00184 Ciclosporin (JP16); Cyclosporine (USP)
D00238 Azathioprine (JP16/USP/INN)
D01583 Pirfenidone (JAN/USAN/INN)
D00314 Etidronate disodium (JP16/USP)
D00941 Pamidronate disodium hydrate (JAN); Pamidronate disodium (USAN)
D00939 Alendronate sodium hydrate (JP16); Alendronate sodium (USAN)
D03234 Sodium risedronate hydrate (JP16)
D01968 Zoledronic acid hydrate (JAN); Zoledronic acid (USAN)
D01338 Ipriflavone (JP16/INN)
D03684 Denosumab (genetical recombination) (JAN); Denosumab (USAN)
D00026 L-Cysteine (JP16)
D01392 Mizoribine (JP16/INN)
D01670 Nafamostat mesilate (JP16); Nafamostat mesylate (USAN)
D01672 Gabexate mesilate (JP16)
D01684 Ozagrel sodium (JP16)
D01688 Epalrestat (JP16/INN)
D01918 Sivelestat sodium hydrate (JAN); Sivelestat sodium (USAN)
D02280 Sodium L-glutamate hydrate (JAN); Monosodium glutamate (NF)
D04285 Concentrated glycerin - fructose mixt
D05183 Ulinastatin (JP16)
D08754 L-Arginine - L-arginine hydrochloride mixt
D09198 Minodronic acid hydrate (JAN)
|
A05BA01
A06AD11
A06AD12
A16AA01
A16AA01
A16AX01
A16AX06
A16AX07
B02AB04
B02BX04
B02BX05
B03XA01
B03XA01
B03XA01
B03XA01
B03XA02
B05XB01
C02DA01 V03AH01
D03AX05 M09AX01 R01AX09 S01KA01
D06BB05 G01AX02 J05AX05 S01XA10
D11AH01 L04AD02
G03XC01
G03XC02
H05BA01
H05BA04
H05BX01
L01BA01 L04AX03
L01XE10 L04AA18
L04AA06
L04AA13
L04AA19
L04AA24
L04AA27
L04AB01
L04AB04
L04AB05
L04AB06
L04AC05
L04AC08
L04AD01 S01XA18
L04AX01
L04AX05
M05BA01
M05BA03
M05BA04
M05BA07
M05BA08
M05BX01
M05BX04
|
|
|
4 Agents affecting cellular function
|
|
|
5 Crude drugs and Chinese medicine formulations
|
|
|
6 Agents against pathologic organisms and parasites
|
|
|
7 Agents not mainly for therapeutic purpose
|
|
|
8 Narcotics
|